<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Middle East Afr J Ophthalmol</journal-id>
      <journal-id journal-id-type="iso-abbrev">Middle East Afr J Ophthalmol</journal-id>
      <journal-id journal-id-type="publisher-id">MEAJO</journal-id>
      <journal-title-group>
        <journal-title>Middle East African Journal of Ophthalmology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0974-9233</issn>
      <issn pub-type="epub">0975-1599</issn>
      <publisher>
        <publisher-name>Medknow Publications &amp; Media Pvt Ltd</publisher-name>
        <publisher-loc>India</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">26692728</article-id>
      <article-id pub-id-type="pmc">4660543</article-id>
      <article-id pub-id-type="publisher-id">MEAJO-22-517</article-id>
      <article-id pub-id-type="doi">10.4103/0974-9233.164623</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Primary Orbital Lymphomatoid Granulomatosis in a 1-Year-Old Child</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Aboobaker</surname>
            <given-names>Shaheer</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
          <xref ref-type="corresp" rid="cor1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Tinley</surname>
            <given-names>Christopher</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
          <xref ref-type="aff" rid="aff2">2</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1"><label>1</label>Division of Ophthalmology, Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa</aff>
      <aff id="aff2"><label>2</label>Division of Paediatric Ophthalmology, Red Cross War Memorial Children's Hospital, University of Cape Town, Cape Town, South Africa</aff>
      <author-notes>
        <corresp id="cor1"><bold>Corresponding Author:</bold> Dr. Shaheer Aboobaker, Division of Ophthalmology, Groote Schuur Hospital, University of Cape Town, South Africa. E-mail: <email xlink:href="aboobakersh@gmail.com">aboobakersh@gmail.com</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <season>Oct-Dec</season>
        <year>2015</year>
      </pub-date>
      <volume>22</volume>
      <issue>4</issue>
      <fpage>517</fpage>
      <lpage>519</lpage>
      <permissions>
        <copyright-statement>Copyright: &#xA9; Middle East African Journal of Ophthalmology</copyright-statement>
        <copyright-year>2015</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0">
          <license-p>This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Lymphomatoid granulomatosis (LyG) is a rare, angiocentric, angiodestructive, B-cell lymphoproliferative disease, presenting with pulmonary involvement in more than 80% of cases. We describe a case of primary orbital LyG in a 1-year-old child.</p>
      </abstract>
      <kwd-group>
        <kwd>Lymphomatoid Granulomatosis</kwd>
        <kwd>Orbit</kwd>
        <kwd>Pediatric</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro" id="sec1-1">
      <title>INTRODUCTION</title>
      <p>Lymphomatoid granulomatosis (LyG) is a rare, angiocentric, angiodestructive, B-cell lymphoproliferative disease, presenting with pulmonary involvement in more than 80% of cases. We describe a case of primary orbital LyG in a 1-year-old child.</p>
    </sec>
    <sec id="sec1-2">
      <title>CASE REPORT</title>
      <p>The child's mother became concerned about a progressive swelling of the right eye over a period of weeks. There was no relevant previous medical or birth history and the mother tested negative for human immunodeficiency virus (HIV). Examination revealed gross, nonaxial proptosis associated with periorbital edema, erythema, and nasal conjunctival chemosis [<xref ref-type="fig" rid="F1">Figure 1</xref>]. Ocular motility was restricted horizontally and in elevation. On fundoscopy, there was pale disc swelling on the right, with tortuous retinal vessels.</p>
      <fig id="F1" position="float">
        <label>Figure 1</label>
        <caption>
          <p>Right nonaxial proptosis with periorbital edema, erythema, and nasal conjunctival chemosis</p>
        </caption>
        <graphic xlink:href="MEAJO-22-517-g001"/>
      </fig>
      <p>A full blood count showed no leukocytosis and there was no evidence of renal dysfunction. Hepatitis B surface antibody was positive, but hepatitis B surface antigen and core antibody immunoglobulin M were negative. The erythrocyte sedimentation rate was 32 mm (range 0&#x2013;15). The child was HIV negative, and a lumbar puncture showed no abnormalities. However, further immunological testing identified a nonspecific T-cell immunodeficiency, with low T-cell subsets (absolute and percentages). Due to resource limitations, the specific features of the immunodeficiency could not be further elucidated.</p>
      <p>Magnetic resonance imaging revealed a large mass (4.5 cm &#xD7; 4.6 cm), originating in the right orbit. This extended through the medial orbital wall into the ethmoid air cells, with frontal leptomeningeal enhancement [<xref ref-type="fig" rid="F2">Figure 2</xref>]. There was restricted diffusion centrally and enhancement of the lesional rim. Her chest X-ray was normal.</p>
      <fig id="F2" position="float">
        <label>Figure 2</label>
        <caption>
          <p>T1-weighted magnetic resonance imaging showing large medial orbital mass with ethmoidal extension, restricted central diffusion, and rim enhancement</p>
        </caption>
        <graphic xlink:href="MEAJO-22-517-g002"/>
      </fig>
      <p>A transnasal biopsy led to the provisional diagnosis of a diffuse, large B-cell lymphoma. Induction therapy consisting of cyclophosphamide, vincristine, and prednisone was commenced, according to the French Society of Pediatric Ophthalmology LMB89 protocol for large B-cell lymphoma.<xref rid="ref1" ref-type="bibr">1</xref> Later immunohistochemistry showed more than 50 Epstein-Barr virus (EBV) positive cells per high power field (hpf), CD 20 positive B-cells in a background of CD 3 positive T-cells, and tumor cells in and around blood vessels [<xref ref-type="fig" rid="F3">Figure 3</xref>]. These findings are consistent with the diagnosis of LyG Grade III. Ganciclovir was therefore added to her treatment, in addition to methotrexate, cytarabine, and etoposide.<xref rid="ref2" ref-type="bibr">2</xref> Within a week, there was a marked reduction in tumor size on this regime.</p>
      <fig id="F3" position="float">
        <label>Figure 3</label>
        <caption>
          <p>Angiocentric and angiodestructive tumor cells occluding a blood vessel</p>
        </caption>
        <graphic xlink:href="MEAJO-22-517-g003"/>
      </fig>
      <p>She then received two induction doses of rituximab, 1-week apart, followed by 6 maintenance doses at 3 weekly intervals. This led to complete tumor resolution on imaging.</p>
      <sec id="sec2-1">
        <title>Comment</title>
        <p>LyG was first described by Liebow <italic>et al</italic>. in 1972, who reported the largest case series of 152 patients.<xref rid="ref3" ref-type="bibr">3</xref> It is a multisystem disorder, primarily affecting the lungs, but also affects the skin, central nervous system, and kidneys. A mortality rate of 63% has been reported, due to either respiratory failure or progression to malignant lymphoma. The disease is known to be driven by EBV and is often associated with an underlying immunodeficiency.<xref rid="ref3" ref-type="bibr">3</xref><xref rid="ref4" ref-type="bibr">4</xref> The lesion is graded according to the number of EBV-positive cells/hpf. Grade I lesions exhibit &lt;5 EBV positive cells/hpf; Grade II between 5 and 50 EBV positive cells/hpf; and Grade III &gt;50 EBV positive cells/hpf.<xref rid="ref2" ref-type="bibr">2</xref> Histological features required for diagnosis include: A mixed mononuclear infiltrate of small and large lymphoid cells; CD20 positive large B-cells in a background of CD3 positive small T lymphocytes; central necrosis and positive immunohistochemistry for EBV.<xref rid="ref5" ref-type="bibr">5</xref></p>
        <p>To date, there have been 22 reported cases of LyG with ophthalmic manifestations.<xref rid="ref6" ref-type="bibr">6</xref> These include conjunctival, pupillary, choroidal, retinal, optic nerve, and orbital (including lacrimal gland) involvement.<xref rid="ref6" ref-type="bibr">6</xref><xref rid="ref7" ref-type="bibr">7</xref><xref rid="ref8" ref-type="bibr">8</xref> All but one of these cases were described in association with pulmonary or other systemic involvement. The only other report of primary orbital involvement occurred in an otherwise healthy 54-year-old man.<xref rid="ref8" ref-type="bibr">8</xref> The disease is most common after the fifth decade and is very rare is children. There are three previously reported cases of pediatric ophthalmic LyG, in children of ages 7, 8, and 13. Two had neuro-ophthalmologic manifestations and one had choroidal infiltrates.<xref rid="ref3" ref-type="bibr">3</xref><xref rid="ref6" ref-type="bibr">6</xref><xref rid="ref9" ref-type="bibr">9</xref> All three were secondary manifestations of primary pulmonary LyG. Due to the rarity of the condition, there is no consensus regarding optimal management. Options include corticosteroids, chemotherapeutic agents (singly or in combination), antiviral agents, radiotherapy, as well as newer agents like rituximab.<xref rid="ref10" ref-type="bibr">10</xref> To our knowledge, this is the youngest reported case of LyG and only the second with primary orbital involvement.</p>
      </sec>
      <sec id="sec2-2">
        <title>Financial support and sponsorship</title>
        <p>Nil.</p>
      </sec>
      <sec id="sec2-3">
        <title>Conflicts of interest</title>
        <p>There are no conflicts of interest.</p>
      </sec>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="ref1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Patte</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Auperin</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Michon</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Behrendt</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Leverger</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Frappaz</surname>
              <given-names>D</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The Soci&#xE9;t&#xE9; Fran&#xE7;aise d&#x2019;Oncologie P&#xE9;diatrique LMB89 protocol: Highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia</article-title>
          <source>Blood</source>
          <year>2001</year>
          <volume>97</volume>
          <fpage>3370</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">11369626</pub-id>
        </element-citation>
      </ref>
      <ref id="ref2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wilson</surname>
              <given-names>WH</given-names>
            </name>
            <name>
              <surname>Kingma</surname>
              <given-names>DW</given-names>
            </name>
            <name>
              <surname>Raffeld</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Wittes</surname>
              <given-names>RE</given-names>
            </name>
            <name>
              <surname>Jaffe</surname>
              <given-names>ES</given-names>
            </name>
          </person-group>
          <article-title>Association of lymphomatoid granulomatosis with Epstein-Barr viral infection of B lymphocytes and response to interferon-alpha 2b</article-title>
          <source>Blood</source>
          <year>1996</year>
          <volume>87</volume>
          <fpage>4531</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="pmid">8639820</pub-id>
        </element-citation>
      </ref>
      <ref id="ref3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liebow</surname>
              <given-names>AA</given-names>
            </name>
            <name>
              <surname>Carrington</surname>
              <given-names>CR</given-names>
            </name>
            <name>
              <surname>Friedman</surname>
              <given-names>PJ</given-names>
            </name>
          </person-group>
          <article-title>Lymphomatoid granulomatosis</article-title>
          <source>Hum Pathol</source>
          <year>1972</year>
          <volume>3</volume>
          <fpage>457</fpage>
          <lpage>558</lpage>
          <pub-id pub-id-type="pmid">4638966</pub-id>
        </element-citation>
      </ref>
      <ref id="ref4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Katzenstein</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Peiper</surname>
              <given-names>SC</given-names>
            </name>
          </person-group>
          <article-title>Detection of Epstein-Barr virus genomes in lymphomatoid granulomatosis: Analysis of 29 cases by the polymerase chain reaction technique</article-title>
          <source>Mod Pathol</source>
          <year>1990</year>
          <volume>3</volume>
          <fpage>435</fpage>
          <lpage>41</lpage>
          <pub-id pub-id-type="pmid">2170969</pub-id>
        </element-citation>
      </ref>
      <ref id="ref5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Katzenstein</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Doxtader</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Narendra</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Lymphomatoid granulomatosis: Insights gained over 4 decades</article-title>
          <source>Am J Surg Pathol</source>
          <year>2010</year>
          <volume>34</volume>
          <fpage>e35</fpage>
          <lpage>48</lpage>
          <pub-id pub-id-type="pmid">21107080</pub-id>
        </element-citation>
      </ref>
      <ref id="ref6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pradeep</surname>
              <given-names>TG</given-names>
            </name>
            <name>
              <surname>Cannon</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Dodd</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Selva</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Lacrimal gland involvement in lymphomatoid granulomatosis and review of the literature</article-title>
          <source>J Ophthalmol 2010</source>
          <year>2010</year>
          <comment>pii: 358121</comment>
        </element-citation>
      </ref>
      <ref id="ref7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pearson</surname>
              <given-names>AD</given-names>
            </name>
            <name>
              <surname>Craft</surname>
              <given-names>AW</given-names>
            </name>
            <name>
              <surname>Howe</surname>
              <given-names>JM</given-names>
            </name>
          </person-group>
          <article-title>Choroidal involvement in lymphomatoid granulomatosis</article-title>
          <source>Br J Ophthalmol</source>
          <year>1991</year>
          <volume>75</volume>
          <fpage>688</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">1751466</pub-id>
        </element-citation>
      </ref>
      <ref id="ref8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Araki</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Mimura</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Fukuoka</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Tsuji</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Izutsu</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Yamamoto</surname>
              <given-names>H</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Primary orbital lymphomatoid granulomatosis</article-title>
          <source>Br J Ophthalmol</source>
          <year>2009</year>
          <volume>93</volume>
          <fpage>554</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="pmid">19321483</pub-id>
        </element-citation>
      </ref>
      <ref id="ref9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Moertel</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Carlson-Green</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Watterson</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Simonton</surname>
              <given-names>SC</given-names>
            </name>
          </person-group>
          <article-title>Lymphomatoid granulomatosis after childhood acute lymphoblastic leukemia: Report of effective therapy</article-title>
          <source>Pediatrics</source>
          <year>2001</year>
          <volume>107</volume>
          <fpage>E82</fpage>
          <pub-id pub-id-type="pmid">11331732</pub-id>
        </element-citation>
      </ref>
      <ref id="ref10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jordan</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Grothey</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Grothe</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Kegel</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Wolf</surname>
              <given-names>HH</given-names>
            </name>
            <name>
              <surname>Schmoll</surname>
              <given-names>HJ</given-names>
            </name>
          </person-group>
          <article-title>Successful treatment of mediastinal lymphomatoid granulomatosis with rituximab monotherapy</article-title>
          <source>Eur J Haematol</source>
          <year>2005</year>
          <volume>74</volume>
          <fpage>263</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="pmid">15693798</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
